India Approves First Dengue Vaccine QDENGA

1. 📣
   21 Jul 2026, 03:08 pmannouncement

   CDSCO Formalizes Authorization for Qdenga Vaccine

   The regulatory body finalized market clearance for Takeda's immunization product, marking a major milestone in vector-borne disease management. Public health officials highlighted that the rollout will target individuals within the defined age demographic to curb seasonal outbreaks.

   backfill:India Top News:2026-07-21 ↗
2. 📣
   20 Jul 2026, 01:01 pmannouncement

   DCGI Clears Takeda's Qdenga as India's First Dengue Vaccine

   The Drugs Controller General of India officially granted marketing authorization for Qdenga, making it the nation's premier approved vaccine against dengue. The immunization is cleared for administration to individuals ranging from 4 to 60 years of age.

   backfill:India Top News:2026-07-20 ↗